APA (7th ed.) Citation

K, H., D, A. R., A, A. G., I, M., W, D., & M, H. (2022). The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia. Hematology/oncology and stem cell therapy, 15(4), 219. https://doi.org/10.1016/j.hemonc.2021.07.003

Chicago Style (17th ed.) Citation

K, Halahleh, Al Rimawi D, Abu Ghosh A, Muradi I, Da'na W, and Hamadani M. "The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia." Hematology/oncology and Stem Cell Therapy 15, no. 4 (2022): 219. https://doi.org/10.1016/j.hemonc.2021.07.003.

MLA (9th ed.) Citation

K, Halahleh, et al. "The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia." Hematology/oncology and Stem Cell Therapy, vol. 15, no. 4, 2022, p. 219, https://doi.org/10.1016/j.hemonc.2021.07.003.